Marko Miladinov
Marko Miladinov publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as COVID-19 and healthcare impacts, Genetic factors in colorectal cancer and Colorectal Cancer Surgical Treatments.
- World rank
- #1,237,240 of 7,710,434 ranked researchers
- Rank in Serbia
- #612 of 18,168
- Works
- 25
- Citations
- 1.2k
- Citations per work
- 46.2
What does Marko Miladinov research?
Marko Miladinov's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1456.1%
- Medicine1456.1%
- Everything else830.6%
- Life Sciences313.3%
- 1Oncology27% of their works
- 2Molecular Biology13% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Surgery7% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Marko Miladinov's research?
The keywords of their largest research topics: Cancer, Mortality, Adjuvant Chemotherapy, COVID-19, Pandemic, Microsatellite Instability, Molecular Characterization and Preoperative Chemoradiotherapy.
- Sphingolipids
- Mutational Signatures
- Cancer Genomics
- Smad-dependent pathways
- Cetuximab
- Preoperative Chemoradiotherapy
- Microsatellite Instability
- COVID-19
- Mortality
- Cancer
- Adjuvant Chemotherapy
- Pandemic
- Molecular Characterization
- Rectal Cancer
- KRAS Mutations
- Tumor Suppression
- Cardiac Risk
- Perioperative
- Sphingosine-1-Phosphate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer102 topics
- Mortality102 topics
- Adjuvant Chemotherapy92 topics
- COVID-1981 topic
- Pandemic81 topic
- Microsatellite Instability51 topic
- Molecular Characterization51 topic
- Preoperative Chemoradiotherapy41 topic
- Rectal Cancer41 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Smad-dependent pathways31 topic
- Tumor Suppression31 topic
- Cancer Genomics21 topic
- Cardiac Risk21 topic
- Mutational Signatures21 topic
- Perioperative21 topic
- Sphingolipids21 topic
- Sphingosine-1-Phosphate21 topic
Where does Marko Miladinov work?
Marko Miladinov's main affiliation in the publication record is University of Belgrade, Serbia.
How many publications and citations does Marko Miladinov have?
OpenAlex counts 25 works and 1,156 citations for Marko Miladinov, an h-index of 11, ranking #1,237,240 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marko Miladinov. Posts are plain text and can be reported.